Assenagon Asset Management S.A.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1546007
SENNINGERBERG, N4
Position in VRTX
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$239,902,721
-$137,679,515 QoQ
Shares Held
537,248
-35.5% QoQ
Ownership
0.212%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Assenagon Asset Management S.A. holds $1,400,134,578 across 60 Biotechnology names. VRTX ranks #1 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
537,248 | $239,902,721 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
7,076,488 | $196,018,717 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
207,788 | $160,545,320 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
865,958 | $146,364,221 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,920,658 | $108,497,970 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
1,280,194 | $89,805,609 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
1,164,813 | $67,687,283 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
320,000 | $60,496,000 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $239,902,721 | 537,248 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $377,582,236 | 832,853 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $299,096,642 | 763,703 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $108,074,080 | 242,754 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $100,910,434 | 208,140 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $338,135,914 | 839,672 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $144,938,926 | 311,643 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $45,088,520 | 96,195 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $135,054,014 | 323,088 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $120,501,694 | 296,153 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $70,323,807 | 202,231 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $135,386,111 | 384,718 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $194,964,055 | 618,796 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $213,404,665 | 738,987 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $191,743,521 | 662,235 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $145,403,076 | 515,998 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $211,008,337 | 808,554 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $70,761,927 | 322,231 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $12,602,795 | 69,479 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $47,610,488 | 236,128 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $58,828,071 | 273,759 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $141,436,727 | 598,446 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $33,828,869 | 124,316 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $36,471,645 | 125,630 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $182,643,519 | 767,571 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||